评价 的 评价.
Elena Lastraioli1,2, Alessandra Bettiol1, Jessica Iorio1
1Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
使用BEAMing技术的液体活检可以检测转移性结直肠癌患者的K-RAS和N-RAS突变. 这种方法对监测治疗反应和预测疾病进展比传统成像更早有希望.
科学领域:
- 在瘤学瘤学.
- 分子诊断学 分子诊断
- 遗传学 遗传学 是一个
背景情况:
- 转移性结直肠癌 (mCRC) 的管理依赖于准确的RAS突变状态.
- 用于RAS突变分析的组织活检可能是侵入性的,可能不反映瘤异质性.
- 液体活检为分子分析提供了一个不那么侵入性的替代方案.
研究的目的:
- 评估BEAMing技术在mCRC患者的血样本中检测K-RAS和N-RAS突变的诊断性能.
- 为了比较液体活检的灵敏度和特异性与基于组织的RAS分析.
- 探索RAS突变等位基因分数与临床参数之间的相关性,以及其监测疾病进展的潜力.
主要方法:
- 从mCRC患者的血样本使用BEAMing技术分析K-RAS和N-RAS突变.
- 结果与从组织活检中确定的RAS突变状态进行了比较.
- 分析了与瘤特征,转移,治疗和疾病进展相关的突变等位基因分数 (MAF) 水平.
主要成果:
- BEAM显示KRAS突变的灵敏度为89.5%,具有相当的特异性;与组织分析的一致性是中等的.
- 对于NRAS突变,观察到高灵敏度和良好的特异性,与组织分析相当一致.
- 较高的MAF水平与G2瘤,肝转移,没有手术,粘膜腺癌和肺转移有关.
- 在MAF显著增加之前,有疾病进展的放射性迹象,这表明分子进展预测了放射性进展.
结论:
- 使用BEAMing技术进行液体活检是检测mCRC中的RAS突变的可行工具.
- 这种方法可以有效地监测治疗反应,并比放射性评估更早地预测疾病的进展.
- 这些发现支持使用液体活检来改善患者管理和及时治疗干预mCRC.
更多相关视频
08:24The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies
Published on: August 25, 2023
05:58Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
相关概念视频
Nursing Evaluation
Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
Self-Evaluation: Self-Enhancement and Self-Verification
Role of Communication in the Nursing Process III: Evaluation and Documentation
Lazarus's Cognitive Appraisal Theory
Primary Appraisal:...
Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
